Biotech Values

[iwfal]

Re: Phase-2 data for PFE’s PD-991

Thus, it’s reasonable to infer that the HR for PFS in part 2 of the study was even better than the superb blended HR of 0.37 (95% CI: [0.21-0.63]).

Add to this that the PFS data was stronger than the ORR data - which substantially increases the odds that the OS data will be even stronger than the PFS data. May be even a more spectacular breakthrough than Criz or Xalkori.